We reviewed 78 GLP-1 sample programs across Ozempic, Wegovy, Zepbound, Mounjaro, and compounded alternatives. Editor-ranked, reader-verified, updated weekly.
Compounded GLP-1 telehealth via state-licensed pharmacies — flat monthly pricing, no insurance routing, same-week shipping. Editor-rated #2 on glp1samples 2026-05-15 after proven conversion.
Established compounded GLP-1 telehealth — semaglutide and tirzepatide via US-licensed pharmacies, with strong consumer-review track record.
High-payout compounded GLP-1 affiliate — US-licensed pharmacy partners, telehealth-only intake.
Ranked by editor review × reader trust × current sample availability.
Compounded GLP-1 telehealth via state-licensed pharmacies — flat monthly pricing, no insurance routing, same-week shipping. Editor-rated #2 on glp1samples 2026-05-15 after proven conversion.
Established compounded GLP-1 telehealth — semaglutide and tirzepatide via US-licensed pharmacies, with strong consumer-review track record.
High-payout compounded GLP-1 affiliate — US-licensed pharmacy partners, telehealth-only intake.
Compounded GLP-1 telehealth program with US-licensed clinicians, transparent monthly pricing, and same-week intake.
Direct-affiliate compounded GLP-1 telehealth — semaglutide and tirzepatide via US-licensed pharmacies.
The honest comparisons most consumer pages won't write. Real cost, real clinical data, and a recommendation for which fits which patient.
Wegovy vs. Zepbound for 2026: real cost, weight loss percentage, eligibility, savings cards, and side effect profile compared head-to-head by an independent editorial team.
Ozempic vs. Mounjaro for Type 2 diabetes in 2026: A1C reduction, weight loss, savings cards, eligibility, and side effects compared head-to-head.
Ozempic vs. Wegovy for 2026: same semaglutide molecule, different doses, different FDA indications. Cost, coverage, and which to ask for compared.
Mounjaro vs. Zepbound for 2026: same tirzepatide molecule, different FDA indications. Cost, coverage, and which to ask for compared.
Compounded semaglutide and tirzepatide vs. brand-name Ozempic, Wegovy, Mounjaro, and Zepbound in 2026: cost, legality, safety, and which path fits which patient.
Semaglutide vs. tirzepatide for 2026: head-to-head clinical data, weight loss percentages, A1C reduction, side effects, cost across every brand (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus) and compounded forms.
The honest answer to “where do I get a free GLP-1 sample” is rarely a free pen — it's the right combination of insurance, prior authorization, and a clinician who knows where the actual pricing levers are.
Brand-specific samples, savings cards, and compounded alternatives — one editorial page per medication, written from the actual 2026 access landscape.
BMI thresholds, comorbidities, and insurance criteria for every GLP-1.
Compounded $179, LillyDirect $399, NovoCare $499 — every legitimate cash path.
Week 5 is the worst — here's how to push through with eating, hydration, timing.
GLP-1 Samples started because the GLP-1 access market in 2026 is genuinely confusing, and the existing comparison sites are either advertising platforms dressed up as editorial or clinical sites that won't name pricing. We're the third option: a small editorial team that reviews every program in our pipeline against publicly disclosed pricing, names the pharmacy partners, publishes the real first-month price, and ranks programs by what actually delivers — not what the homepage banner promises.
We make money the same way every reputable comparison site makes money: affiliate commissions when readers start a consult through one of the links here. We disclose the relationship on every page; partners cannot pay for ranking position; the editorial team has independent authority to remove or downgrade any program. Reader feedback tells us when an offer changes or stops working, and we update the ranking within 24 hours when something material moves.
Mostly no, in the literal sense. Federal sampling rules route branded samples through prescribers, not patients. The closest consumer-facing equivalent is the manufacturer savings card, which can drop eligible commercially insured patients to $0–$25/month. Compounded GLP-1 programs are typically the cheapest cash-pay path at $179–$249/month. The detail depends on your insurance and which drug you're seeking.
For commercially insured patients on a covered drug: the manufacturer savings card ($0–$25/month). For cash-pay patients: compounded semaglutide at $179–$349/month or LillyDirect Zepbound vials at $399/month. For federal-plan enrollees (Medicare, Medicaid, VA, Tricare) — savings cards are excluded, so compounded becomes the practical lowest-cost path.
Wegovy and Zepbound require BMI ≥30, or ≥27 with a weight-related comorbidity. Ozempic and Mounjaro require a Type 2 diabetes diagnosis. The 60-second eligibility quiz on this site walks you through your specific situation.
On clinical weight-loss percentage, Zepbound wins (20.9% at 15 mg vs. Wegovy's 14.9% at 2.4 mg). On cardiovascular outcomes, Wegovy has the SELECT trial data. On cash-pay cost, Zepbound's $399 LillyDirect vials beat NovoCare's $499 Wegovy. Insurance coverage usually picks for you.
Yes, when prescribed by a licensed clinician for an individual patient and prepared at a state-licensed 503A or 503B pharmacy with documented clinical justification. The FDA declared semaglutide off the shortage list in early 2025 and tirzepatide off in late 2024 — broad mass-prep ended, individual prescriptions continue.
Editor rating from editorial review × reader-verified active-offer score × pricing transparency × clinician credential verification. Rankings are earned by the provider, not the deal — affiliate commissions fund the work, they don't pick the winners.
Programs are re-verified weekly. Pricing and offer changes get reflected within 24 hours. The live ticker at the top of the site shows the most recent verification timestamp.
We're not a telehealth provider. We don't prescribe, we don't take a clinical fee, and we have no incentive to push any single program. We earn affiliate commissions when you start a consult through one of the links here, but our ranking is editorial — partners cannot pay for placement.
Most major programs cover all 50 states; a few exclude states with stricter telemedicine rules. Each provider page shows current state availability. The eligibility quiz filters for your state.
Weekly drop: fresh manufacturer savings cards, new sample programs, this week's lowest cash prices, and any provider that just cut their first-month rate. Free. No spam. Unsubscribe in one click.